Clinical evaluation of plasma exchange and high dose intravenous immunoglobulin in a patient with Isaacs' syndrome

Ishii, A; Hayashi, A; Ohkoshi, N; Oguni, E; Maeda, M; Ueda, Y; Ishii, K; Arasaki, K; Mizusawa, H; Shoji, S
July 1994
Journal of Neurology, Neurosurgery & Psychiatry;Jul1994, Vol. 57 Issue 7, p840
Academic Journal
journal article
No abstract available.


Related Articles

  • Successful treatment of a hypothalamic lesion in neuromyelitis optica by plasma exchange. Watanabe, Shohei; Nakashima, Ichiro; Miyazawa, Isabelle; Misu, Tatsuro; Shiga, Yusei; Nakagawa, Yoichi; Fujihara, Kazuo; Itoyama, Yasuto // Journal of Neurology;May2007, Vol. 254 Issue 5, p670 

    A letter to the editor is presented regarding the therapeutic efficacy of plasma exchange for a hypothalamic lesion in a neuromyelitis optica-immunoglobulin G-positive neuromyelitis optica patient who is totally unresponsive to high-dose intravenous methylprednisolone.

  • Catastrophic antiphospholipid (Asherson's) syndrome. Cervera, Ricard; Asherson, Ronald A. // British Journal of Hospital Medicine (17508460);Jul2008, Vol. 69 Issue 7, p384 

    The article discusses characteristics and treatment of catastrophic antiphospholipid syndrome. The author stated that the condition is a potentially life-threatening condition with a high mortality. He added that the current basic treatment of the condition is the combination of high doses of...

  • GENERAL CONSIDERATION OF GUILLIAIN BARRE SYNDROME. Gandhi, Zeel A.; Maisuria, Brijal A.; Patel, Rajesh G.; Arora, Bhoomi // International Journal of Pharmaceutical Sciences & Research;Nov2012, Vol. 3 Issue 11, p4135 

    Guillain-Barré syndrome is a rare but important disease that can lead to life threatening respiratory failure. This review summarises the verified consideration of Guillain-Barré syndrome (GBS) which are thought to be caused by direct autoimmune attack on peripheral nerves. Aim- Nerve...

  • Intravenous Immunoglobulin G Therapy in Streptococcal Toxic Shock Syndrome: A European Randomized, Double-Blind, Placebo-Controlled Trial. Darenberg, Jessica; Ihendyane, Nahla; Sjölin, Jan; Aufwerber, Ewa; Haidl, Sven; Follin, Per; Andersson, Jan; Norrby-Teglund, Anna // Clinical Infectious Diseases;8/1/2003, Vol. 37 Issue 3, p333 

    Evaluates the efficacy and safety of high-dose intravenous polyspecific immunoglobulin G (IVIG) as adjunctive therapy in streptococcal toxic shock syndrome (STSS). Mortality rate; Decrease in the sepsis-related organ failure assessment score in the IVIG group; Increase in plasma neutralizing...

  • Comparison of treatments for Guillain-Barre syndrome. Walling, Anne D. // American Family Physician;5/15/1997, Vol. 55 Issue 7, p2510 

    Presents a summary of the article `Plasma Exchange/Sandoglobulin Guillain-Barre Syndrome Trial Group: Randomized Trial of Plasma Exchange, Intravenous Immunoglobulin and Combined Treatments in Guillain-Barre Syndrome,' from `Lancet,' 1997. Role of plasma exchange and intravenous immunoglobulin...

  • Review: Plasma exchange or intravenous immunoglobulin reduces disability in the Guillain-Barré syndrome.  // ACP Journal Club;May/Jun2004, Vol. 140 Issue 3, p76 

    This article presents a study, which states that in patients with the Guillain-Barr é syndrome (GBS), immunotherapy is consisting of plasma exchange, intravenous immunoglobulin (IgIV), or steroids are effective for reducing GBS-related disability. Studies were selected if they were randomized...

  • Review: Plasma exchange or intravenous immunoglobulin reduces disability in the Guillain-Barré syndrome: COMMENTARY. Bleck, Thomas P. // ACP Journal Club;May/Jun2004, Vol. 140 Issue 3, p76 

    The value of treating patients with Guillain-Barr syndrome (GBS) with plasma exchange or intravenous immunoglobulin (IgIV) is beyond dispute. However, data from randomized clinical trials do not help a clinician choose between the agents for individual patients. This choice should consider the...

  • Lenalidomide cutaneous adverse event: a case of Stevens-Johnson syndrome (SJS) in a primary plasma cell leukaemia patient treated with lenalidomide and dexamethasone. Siniscalchi, A.; Tendas, A.; Morino, L.; Dentamaro, T.; Bellis, A.; Perrotti, A.; Fabritiis, P.; Musto, P.; Caravita, T. // Supportive Care in Cancer;Jul2012, Vol. 20 Issue 7, p1585 

    The article describes a case of a Stevens-Johnson syndrome (SJS) that developed in plasma cell leukaemia during Revlimid and dexamethasone treatment in a 51-year-old man. The laboratory test results of the patient is presented, which include leukocytosis with peripheral plasma cells,...

  • 10 year-old-girl with life-threatening idiopathic systemic capillary leak syndrome: a case report. Iwasa, Tadashi; Ohashi, Hiroyuki; Kihira, Kentaro; Koike, Yuhki; Otake, Kohei; Inoue, Mikihiro; Sawada, Hirofumi; Toyoda, Hidemi; Komada, Yoshihiro // BMC Pediatrics;2014, Vol. 14 Issue 1, p1 

    Background Idiopathic systemic capillary leak syndrome (ISCLS) is a rare disorder, characterized by episodic life-threatening hypotension, hypoalbuminemia, and hemoconcentration. Case presentation A 10 year old girl presented with abdominal pain, vomiting, diarrhea, fever and developed...

  • Intravenous Immunoglobulin in Autoimmune Neuromuscular Diseases. Dalakas, Marinos C. // JAMA: Journal of the American Medical Association;5/19/2004, Vol. 291 Issue 19, p2367 

    Context Intravenous immunoglobulin (IVIG) enhances immune homeostasis by modulating expression and function of Fc receptors, interfering with activation of complement and production of cytokines, providing anti-idiotypic antibodies, and affecting the activation and effector functions of T and B...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics